Find answers to common questions about using the Dexcom G7 CGM with your insulin pump.

Choose your pump

The Tandem Mobi System and Tandem t:slim X2 Insulin Pump shown side by side

Tandem Mobi System

Important: Please make sure your Dexcom G7 sensors are compatible with your Tandem Mobi system by referencing the instructions on our Dexcom Compatibility page.

Connect Dexcom G7

View Guide

Learn how to insert and stop the Dexcom G7 CGM with your pump.

Connection Tips

View Guide

See how to troubleshoot a lost sensor signal on the mobile app.

Caring

Who to Contact for CGM Support

Left-pointing double arrow

Review other Training Materials to learn more.

Important Safety Information

RX ONLY.

Indications for Use

Tandem Mobi insulin pump with interoperable technology: The Tandem Mobi insulin pump with interoperable technology (the pump) is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in persons requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient, home use and requires a prescription. The pump is indicated for use in individuals 6 years of age and greater.

Control-IQ technology: Control-IQ technology is intended for use with a compatible iCGM (sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons 6 years of age and greater. Control-IQ technology is intended for single patient use. Control IQ-technology is indicated for use with NovoLog or Humalog U-100 insulin.

Warning: Control-IQ technology should not be used by anyone under the age of 6 years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of a Tandem insulin pump and Control-IQ technology must use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The Tandem pump, and the CGM transmitter (when applicable) and sensor must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.

t:slim X2 Insulin Pump

Important: Please make sure your Dexcom G7 sensors are compatible with your t:slim X2 insulin pump by referencing the instructions on our Dexcom Compatibility page.

Start Dexcom G7

View Guide

Learn how to start a new Dexcom G7 sensor.

Stop Dexcom G7

View Guide

Learn how to stop a Dexcom G7 sensor.

Caring

Who to Contact for CGM Support

Left-pointing double arrow

Review other Training Materials to learn more.

Important Safety Information
RX ONLY. The t:slim X2 insulin pump with interoperable technology is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The pump is intended for single patient use. The pump is indicated for use with NovoLog or Humalog U-100 insulin. The pump is indicated for use in individuals 6 years of age and greater. Users of the pump must: be willing and able to use the insulin pump and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts. The t:slim X2 pump must be removed before MRI, CT, or diathermy treatment. Visit tandemdiabetes.com/safetyinfo for additional important safety information.